Dainippon Sumitomo Pharma Spins Off Two Non-Rx Drug Subsidiaries
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharma announced Nov. 27 a plan to spin off two subsidiaries that are not related to its therapeutic drug business